About 135,000 results
Open links in new tab
  1. News Release - Eli Lilly and Company

  2. Tirzepatide cuts risk of diabetes by 94% in adults with ... - CNN

  3. FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity ... - CNN

  4. Mounjaro leads to significantly more weight loss than Ozempic ... - CNN

  5. Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says

  6. News Release - Eli Lilly and Company

  7. Lilly hits record high after Mounjaro fuels forecast raise, rival data

  8. Drugmaker Lilly slates another $4.5B for ... - Associated Press News

  9. Eli Lilly Zepbound, Mounjaro available after shortages, FDA says

  10. New analyses of Mounjaro™ (tirzepatide ... - Eli Lilly and Company